The effects of seasons and light therapy on G protein levels in mononuclear leukocytes of patients with seasonal affective disorder

被引:33
作者
Avissar, S
Schreiber, G
Nechamkin, Y
Neuhaus, I
Lam, GK
Schwartz, P
Turner, E
Matthews, J
Naim, S
Rosenthal, NE
机构
[1] Ben Gurion Univ Negev, Dept Clin Pharmacol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Dept Psychiat, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
[3] NIMH, Clin Psychobiol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1001/archpsyc.56.2.178
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Information-transducing heterotrimeric G proteins have been implicated previously in the mechanism of action of mood stabilizers and in the pathophysiology of mood disorders. Mononuclear leukocytes of patients with unipolar and bipolar depression have been characterized by reduced measures of the stimulatory and inhibitory G proteins. In this study, patients witt; seasonal affective disorder (SAD) were measured for mononuclear leukocyte G protein levels while depressed during the winter, following light therapy, and in remission during the summer. Methods: Twenty-six patients with SAD and 28 healthy subjects were assessed in the study. The immunoreactivities of G(5)alpha, G(i)alpha, and G beta subunit proteins were de termined by Western blot analysis of mononuclear leukocyte membranes with selective polyclonal antibodies for the various G subunit proteins, followed by densitometric quantitation using an image analysis system. Results: Untreated patients with SAD and winter, atypical-type depression showed significantly reduced mononuclear leukocyte immunoreactive levels of G(s)alpha and G(i)alpha proteins, similar to previous observations in patients with nonseasonal major depression. The reduced G protein levels were normalized with 2 weeks of light therapy. The same patients while in remission during the summer had G protein levels that were similar to those of healthy subjects. Conclusions: G protein-immunoreactive measures in patients with SAD are suggested as a state marker for winter depression, which is normalized by light treatment and during the summer. We speculate that light may ex ert its effects via normalization of transducin (G, protein) levels, which are thought to be reduced in winter depression.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 46 条
[1]   INTERACTION OF ANTIBIPOLAR AND ANTIDEPRESSANT TREATMENTS WITH RECEPTOR-COUPLED G-PROTEINS [J].
AVISSAR, S ;
SCHREIBER, G .
PHARMACOPSYCHIATRY, 1992, 25 (01) :44-50
[2]   MAGNESIUM REVERSAL OF LITHIUM INHIBITION OF BETA-ADRENERGIC AND MUSCARINIC RECEPTOR COUPLING TO G-PROTEINS [J].
AVISSAR, S ;
MURPHY, DL ;
SCHREIBER, G .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (02) :171-175
[3]  
Avissar S, 1997, AM J PSYCHIAT, V154, P211
[4]   THE INVOLVEMENT OF GUANINE-NUCLEOTIDE BINDING-PROTEINS IN THE PATHOGENESIS AND TREATMENT OF AFFECTIVE-DISORDERS [J].
AVISSAR, S ;
SCHREIBER, G .
BIOLOGICAL PSYCHIATRY, 1992, 31 (05) :435-459
[5]   Reduced beta-adrenergic receptor-coupled Gs protein function and Gs alpha immunoreactivity in mononuclear leukocytes of patients with depression [J].
Avissar, S ;
BarkiHarrington, L ;
Nechamkin, Y ;
Roitman, G ;
Schreiber, G .
BIOLOGICAL PSYCHIATRY, 1996, 39 (09) :755-760
[6]   Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent [J].
Avissar, S ;
Nechamkin, Y ;
BarkiHarrington, L ;
Roitman, G ;
Schreiber, G .
JOURNAL OF AFFECTIVE DISORDERS, 1997, 43 (02) :85-93
[7]   BENNETT,AE AWARD PAPER MUSCARINIC RECEPTOR SUBCLASSIFICATION AND G-PROTEINS - SIGNIFICANCE FOR LITHIUM ACTION IN AFFECTIVE-DISORDERS AND FOR THE TREATMENT OF THE EXTRAPYRAMIDAL SIDE-EFFECTS OF NEUROLEPTICS [J].
AVISSAR, S ;
SCHREIBER, G .
BIOLOGICAL PSYCHIATRY, 1989, 26 (02) :113-130
[8]   LITHIUM INHIBITS ADRENERGIC AND CHOLINERGIC INCREASES IN GTP BINDING IN RAT CORTEX [J].
AVISSAR, S ;
SCHREIBER, G ;
DANON, A ;
BELMAKER, RH .
NATURE, 1988, 331 (6155) :440-442
[9]   Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression [J].
Avissar, S ;
Nechamkin, Y ;
Roitman, G ;
Schreiber, G .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (05) :666-671
[10]  
AVISSAR S, 1990, EUR J PHARM-MOLEC PH, V100, P99